Plasbumin Solution
Product Images NDC 13533-690

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasbumin (NDC 13533-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (Label5)

Plasbumin 2.5 g/50 mL solution for intravenous use containing Albumin (Human) 5%, USP. The single-dose vial label from Grifols Therapeutics LLC shows dosing information, storage instructions, and specific warnings including not to use if the solution is turbid and to discard any unused portion.*

FDA Label Image

Carton Label (Carton5)

Packaging label for Plasbumin 2.5 g/50 mL solution for intravenous infusion, containing Albumin (Human) 5% USP. The label states product details, storage instructions to keep at room temperature below 30°C, and warnings against use if the shrink band is absent or signs of tampering. Manufactured by Grifols USA, LLC, the label includes barcode, NDC 13533-690-20, and instructions for single-dose vial use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.